68 posts categorised "Pharmaceutical and life sciences"

24 May 2021 Inclusion and diversity – why it matters in pharma and how to make it work Pharma companies that invest in diversity are likely to create more healthy organisations. Read our thoughts on making I&D integral.

13 April 2021 Supporting and recruiting talent in the pharma industry post-Brexit and COVID-19 Brexit is impacting employers in the pharmaceuticals sector more than in most parts of the economy as the industry relies heavily on expertise from overseas. Our latest blog sets out some recommended steps to take now.

18 March 2021 Pharma with a purpose There has never been a better time for the pharma industry to shift the way it thinks and the way it acts to redefine its relationships with stakeholders. Read our blog highlighting the role of purpose for the sector

17 February 2021 Towards a Net Zero future in pharma - the role of continuous manufacturing How can Continuous Manufacturing support pharma to meet enhanced global Net Zero and waste reduction targets?

15 January 2021 Taxing continuous manufacturing - seven considerations The operational benefits of continuous manufacturing are clear but what are the tax implications? We set out what the sector needs to consider.

13 November 2020 Three reasons continuous manufacturing can deliver innovation and agility to help transform the pharma industry Increasing value of supply chain agility strengthens the case to make continuous manufacturing a common option for product manufacture in the next 5-10 years.

16 September 2020 Back to the future. Why patients must be at the heart of the post-COVID-19 health system Anthony Bruce and Karla Anderson set out why patients are key in a post COVID-19 environment.

10 September 2020 Why UK health and social care needs a new system architecture after COVID-19 David Morris discusses the need around new system architecture following the government's recent August folding of (PHE) into (NIHP).

24 July 2020 Can continuous manufacturing fix pharma's shortfalls? COVID-19 has pushed the pharmaceutical sector to the forefront of public consciousness. Johnathon Marshall considers if continuous manufacturing can fix pharma's shortfalls.

13 March 2020 UK pharmaceutical and life sciences: what will the next decade have in store? The UK has historically been at the forefront of developing innovative new treatments and medical technologies. We look ahead to the next decade for what could be in store.

05 February 2020 Heal yourself, patient journeys as a strategic tool for pharmaceutical companies As patients are increasingly engaged in their own healthcare, and as their needs are evolving, pharmaceutical companies now have the ambition and the need to achieve greater patient centricity.

23 January 2020 How can technology help deliver the NHS Long Term Plan? A view from the board The effective use of technology is critical in delivering the NHS Long Term PLan (LTP), but how can this be implemented, and how do current NEDs feel about the role of technology within healthcare?

23 January 2020 Patient needs are changing - is the answer precision medicine? In this blog Nick Meadows and Katharina Franke explore whether precision medicine is the answer to the changing needs of patients.

23 January 2020 System planning in health and care - getting the numbers right Getting a single view of the system’s prospective financial performance should be taking on increased importance for Integrated Care System (ICS) and Integrated Care Partnership (ICP) leaders, as well as for boards and governing bodies. In this blog, Joshua Walker discusses the need for system planning in healthcare.

29 November 2019 Winning the superbug battle - what is it going to take? (Part 2) By Dragos Mircea and David Leonard. Antibiotics appear to be bad business. Several interventions can change this, one of which is a Market Entry Reward (MER).

14 November 2019 Winning the superbug battle - what is it going to take? (Part 1) By Dragos Mircea and David Leonard. If left unchecked, rising antimicrobial resistance may bring us back to the pre-antibiotics era. In this two part series we will share our views on the challenge ahead.

26 September 2019 Bold action needed on social determinants to improve health outcomes We know that the social, economic and environmental factors of where we live and work, such as social isolation, economic inequality, pollution and poor food can greatly influence an individual's health. Here we set out an action plan for tackling these health inequalities.

08 August 2019 Digitising the clinical supply chain By Jai Dongre. Over the last few decades, clinical trials have become exponentially more complex. While new technology has been slowly adopted to increase efficiency, there is still a significant opportunity to further optimise supply and logistics during clinical development.

04 July 2019 Data sharing in the age of AI driven drug discovery By Krishna Vallurupalli. Although most big pharma companies collaborate with AI startups and tech companies, data still remains the bottleneck to train AI engines to deliver quality outputs for better drug design.

04 July 2019 Implementing the NHS Long Term Plan - Are there lessons from abroad? By Mike Farrar. We are not alone in having increasing demand outstripping new resources.

Popular categories

Follow PwC